SEC Appoints New Chairman and Board Members to PCAOB

The SEC announced the appointment of Demetrios Logothetis as Chairman and three new members to the Public Company Accounting Oversight Board (PCAOB). These appointments are intended to usher in a new era of sensible and efficient oversight of auditors, focusing on the PCAOB's core mission of investor protection.

SEC Publishes Data on ETFs, Fund Mergers, and Advisors

The SEC's Division of Economic and Risk Analysis has published new reports on active ETFs and fund mergers, along with updated statistics for municipal advisors, transfer agents, and security-based swap dealers. These publications provide data and analysis on market trends and investor fee impacts.

SEC v. Ryan Squillante - Insider Trading Enforcement

The SEC announced a final consent judgment against Ryan Squillante for insider trading. Squillante was ordered to pay disgorgement and prejudgment interest totaling $250,765, which was satisfied by a criminal fine in a parallel case. The SEC alleges he used confidential information to trade in at least ten securities.

SEC Obtains Judgments Against Shvartsman Brothers for Insider Trading

The SEC announced it obtained final consent judgments against Gerald and Michael Shvartsman for insider trading in DWAC securities, resulting in disgorgement of over $22 million. The action also involved parallel criminal proceedings, and the SEC voluntarily dismissed its claims against Rocket One Capital LLC.

SEC Charges Marat Likhtenstein with $4 Million Offering Fraud

The SEC has charged Marat Likhtenstein with an offering fraud scheme that raised over $4.1 million. Likhtenstein allegedly misappropriated investor funds for personal expenses and Ponzi-like payments. He consented to injunctive relief, with monetary relief to be determined.

SEC Charges CBA Pharma and Two Executives with Fraud

The SEC has charged CBA Pharma, Inc. and two executives with defrauding investors in a securities offering that raised approximately $4.1 million. The company allegedly misrepresented the effectiveness and FDA approval status of its cancer drug, CBT-1.

SEC v. Barrington Asset Management - Enforcement Action Dismissal and Settlement

The SEC has dismissed its civil enforcement action against Barrington Asset Management, Inc. and Gregory D. Paris. Simultaneously, the SEC instituted a settled administrative proceeding against the same parties. The dismissal and settlement occurred on February 10, 2026.

SEC Technical Amendments to Commission Forms

The SEC has issued a final rule making technical amendments to its commission forms. These amendments are administrative in nature and do not alter existing disclosure requirements or regulatory obligations for public companies, broker-dealers, or fund managers.

SEC Technical Amendments to Commission Rules and Forms

The SEC has issued a final rule making technical amendments to its existing rules and forms. This action is part of routine administrative updates to ensure clarity and accuracy in regulatory filings and procedures.

SEC Delegation of Authority to Director of Investment Management

The SEC has issued a final rule amending its delegation of authority to the Director of the Division of Investment Management. This rule clarifies and updates the specific functions and responsibilities that can be delegated to the Director. The changes are effective upon publication in the Federal Register.